v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Share Issuance Obligation [Member]
Retained Earnings [Member]
Total
Beginning Balance at Dec. 31, 2024 $ 12,457 $ 27,630,696   $ (23,198,018) $ 4,445,135
Beginning balance, shares at Dec. 31, 2024 12,456,815        
Common stock          
Issued upon vesting of restricted stock units $ 3 (3)  
Issued upon vesting of restricted stock units, shares 3,763        
Amortization of stock-based compensation 172,415   172,415
Net loss for the period   (1,291,596) (1,291,596)
Stock-based compensation          
Issued upon exercise of stock options $ 2 (2)  
Issued upon exercise of stock options, shares 1,596        
Ending Balance at Mar. 31, 2025 $ 12,462 27,803,106   (24,489,614) 3,325,954
Ending balance, shares at Mar. 31, 2025 12,462,174        
Beginning Balance at Dec. 31, 2024 $ 12,457 27,630,696   (23,198,018) 4,445,135
Beginning balance, shares at Dec. 31, 2024 12,456,815        
Common stock          
Net loss for the period         (2,196,616)
Ending Balance at Jun. 30, 2025 $ 12,577 29,014,740   (25,394,634) 3,632,683
Ending balance, shares at Jun. 30, 2025 12,577,159        
Beginning Balance at Mar. 31, 2025 $ 12,462 27,803,106   (24,489,614) 3,325,954
Beginning balance, shares at Mar. 31, 2025 12,462,174        
Common stock          
Issued upon vesting of restricted stock units $ 4 (4)  
Issued upon vesting of restricted stock units, shares 3,563        
Amortization of stock-based compensation 122,650   122,650
Net loss for the period   (905,020) (905,020)
Issued under At-The-Market offering $ 111 1,122,142   1,122,253
Issued under At-The-Market offering, shares 111,422        
Issuance costs for At-The-Market offering (33,154)   (33,154)
Ending Balance at Jun. 30, 2025 $ 12,577 29,014,740   (25,394,634) 3,632,683
Ending balance, shares at Jun. 30, 2025 12,577,159        
Beginning Balance at Dec. 31, 2025 $ 13,309 37,784,883 (30,189,082) 7,609,110
Beginning balance, shares at Dec. 31, 2025 13,308,985        
Common stock          
Issued upon vesting of restricted stock units $ 5 (5)
Issued upon vesting of restricted stock units, shares 5,175        
Issued upon exercise of warrants $ 8 108,321 108,329
Issued upon exercise of warrants, shares 8,333        
Amortization of stock-based compensation 454,647 454,647
Net loss for the period (1,930,180) (1,930,180)
Ending Balance at Mar. 31, 2026 $ 13,322 38,347,846 (32,119,262) 6,241,906
Ending balance, shares at Mar. 31, 2026 13,322,493        
Beginning Balance at Dec. 31, 2025 $ 13,309 37,784,883 (30,189,082) 7,609,110
Beginning balance, shares at Dec. 31, 2025 13,308,985        
Common stock          
Net loss for the period         (6,135,722)
Ending Balance at Jun. 30, 2026 $ 13,513 41,613,220 4,000,001 (36,923,957) 8,702,777
Ending balance, shares at Jun. 30, 2026 13,512,860        
Beginning Balance at Mar. 31, 2026 $ 13,322 38,347,846 (32,119,262) 6,241,906
Beginning balance, shares at Mar. 31, 2026 13,322,493        
Common stock          
Issued upon vesting of restricted stock units $ 5 (5)
Issued upon vesting of restricted stock units, shares 5,175        
Issued upon exercise of warrants $ 138 1,592,232 1,592,370
Issued upon exercise of warrants, shares 137,597        
Amortization of stock-based compensation 402,544 402,544
Net loss for the period (4,205,542) (4,205,542)
Issued under At-The-Market offering $ 48 567,076 567,124
Issued under At-The-Market offering, shares 47,595        
Issuance costs for At-The-Market offering (16,334) (16,334)
Issuance costs for exercise of warrants 33,959 33,959
Issuable upon registered direct offering 4,000,001 4,000,001
Issuance costs for registered direct offering (26,196) (26,196)
Stock-based compensation          
Reversal of other payables 180,863 180,863
Deemed dividends 599,153 (599,153)
Ending Balance at Jun. 30, 2026 $ 13,513 $ 41,613,220 $ 4,000,001 $ (36,923,957) $ 8,702,777
Ending balance, shares at Jun. 30, 2026 13,512,860